B. Lang

Three-weekly docetaxel (T) plus capecitabine (X) in 1st and 2nd line metastatic esophageal cancer (MEC): Final Results of the phase II DACAPO Trial

F. Lordick, C. Peschel, J. Duyster, 2005 .

A Phase II Trial of Vinorelbine and Pegylated Liposomal Doxorubicin in Patients With Pretreated Metastatic Breast Cancer

L. Chow, A. Yip, B. Lang, 2007, American journal of clinical oncology.